MemoHive Reviews: Announces U.S. Availability of Five-Ingredient Memory Support Dietary Supplement

New two-capsule formula combines Bacopa Monnieri, Rhodiola Rosea, L-Theanine, Panax Ginseng and branched-chain amino acids as company publishes ingredient-level research context for consumers

PINELLAS PARK, Florida, September 17, 2026 — MemoHive has announced the U.S. availability of MemoHive Premium Formula, a capsule dietary supplement containing Bacopa Monnieri extract, Rhodiola Rosea extract, L-Theanine, Panax Ginseng extract and branched-chain amino acids (BCAAs).

The launch marks the company’s entry into the cognitive-wellness supplement category. The product is taken as two capsules daily, and its label lists the amount of each ingredient individually. Alongside the announcement, MemoHive is publishing information on the scientific literature for each ingredient. That material also explains why studies of single ingredients cannot simply be applied to a finished multi-ingredient supplement.

The company said the material is meant to help consumers tell apart two kinds of evidence: published studies of individual botanicals or amino acids, and evidence that evaluates the complete MemoHive formula.

MemoHive has not cited any clinical study showing that the finished formula produces the outcomes reported in studies of isolated Bacopa Monnieri, Rhodiola Rosea, L-Theanine, Panax Ginseng or BCAAs. Published studies often use different extract types, amounts, participant groups and durations than a commercial product does.

“Research citations only help consumers when they come with the right context,” said Kevin Shaw, [Title] at MemoHive. “With this announcement, we want to show exactly what is in the formula and explain why these ingredients keep appearing in nutritional research. We also want to be clear that a study on one ingredient is not clinical evidence for a finished product.”

Learn More About MemoHive on their official Website. 

MemoHive Enters the Cognitive-Wellness Supplement Category

Researchers continue to study how nutrition, sleep, physical activity and specific dietary components relate to everyday memory, focus and mental clarity. Botanical extracts and amino acids are among the dietary components examined in that research.

Government health agencies, including the National Center for Complementary and Integrative Health (NCCIH), have noted that research on many botanical supplements is limited. Studies often differ in preparation, dose, population and method, which makes firm conclusions difficult.

That caution applies to MemoHive Premium Formula because each of its five ingredients has been studied on its own. The formula combines three botanical extracts (Bacopa Monnieri, Rhodiola Rosea and Panax Ginseng) with two amino-acid ingredients (L-Theanine and a BCAA blend).

MemoHive said it is not presenting individual research findings as results of the finished product. Instead, the announcement aims to describe the formula clearly and set out the research context for each component. Find more details about the ingredients of MemoHive on the official website.

Five-Ingredient Formula Provides a Disclosed Label Profile

According to company product information, each two-capsule serving of MemoHive Premium Formula contains 1,030 milligrams of five ingredients. Bacopa Monnieri extract is listed at 200 milligrams, and Rhodiola Rosea extract at 100 milligrams, standardized to 3% salidroside. L-Theanine is listed at 100 milligrams and Panax Ginseng extract at 90 milligrams. The branched-chain amino acids are supplied in a 2:1:1 ratio, and their quantity is shown on the product label.

Because the label lists each amount separately rather than as a proprietary blend, consumers can compare each figure with the doses used in published research. That comparison matters. Seeing an ingredient’s name on a label is not enough to judge whether a study applies. Extract type, standardization, amount, study population and trial duration all affect how a finding should be read.

Bacopa Monnieri Has Been Examined in Randomized Human Trials

Bacopa Monnieri, known in India as Brahmi, is a wetland plant with a long history of use in traditional Ayurvedic practice. It has also been studied in modern clinical trials.

A meta-analysis by Kongkeaw and colleagues, published in the Journal of Ethnopharmacology in 2014, pooled nine randomized controlled trials of Bacopa extracts in adults. It reported changes in some measures of memory-related test performance. The authors also noted differences among the trials in extract preparation, dosing and testing methods.

Most of the trials in that analysis gave the extract daily for about 12 weeks. That means the findings describe specific standardized preparations used over a defined period. Some trials also reported digestive discomfort among participants.

For MemoHive, Bacopa Monnieri is presented as an ingredient that has been studied, not as evidence of a demonstrated effect of the finished product.

Rhodiola Rosea Is Recognized for Traditional Use in Europe

Rhodiola Rosea is a flowering plant that grows in cold, high-altitude regions of northern Europe and Asia. It has been used in traditional practice for centuries.

The European Medicines Agency’s herbal monograph on Rhodiola rosea recognizes it as a traditional herbal medicinal product for temporary relief of stress-related symptoms such as fatigue. The agency bases that status on long-standing use rather than on clinical trial evidence.

NCCIH notes that research on Rhodiola in people is limited, and that existing studies vary in quality and design. The 3% salidroside figure on the MemoHive label refers to a marker compound that researchers use to standardize Rhodiola extracts. Standardization helps keep batches consistent, but it does not show how an extract performs.

L-Theanine Research Often Involves Caffeine, Which the Formula Does Not List

L-Theanine is an amino acid found naturally in the leaves of the tea plant, Camellia sinensis.

A review by Nobre, Rao and Owen in the Asia Pacific Journal of Clinical Nutrition examined research on L-Theanine and alpha-wave activity measured by electroencephalography. Other published studies have looked at L-Theanine and performance on attention tasks. Many of those studies gave L-Theanine together with caffeine.

MemoHive Premium Formula does not list caffeine. Findings from studies that combined L-Theanine with caffeine therefore cannot be applied directly to this formula.

Panax Ginseng Research Has Not Produced Clear Conclusions on Cognition

Panax Ginseng, also called Asian ginseng, has been used in East Asian traditional practice for centuries. It is a different plant from American ginseng and from the unrelated plant sold as Siberian ginseng.

A Cochrane systematic review by Geng and colleagues examined trials of ginseng and cognitive performance. The reviewers concluded there was not enough convincing, high-quality evidence to support cognitive benefit claims. NCCIH also describes research on Asian ginseng as ongoing and notes that ginseng may interact with certain medications.

MemoHive includes Panax Ginseng as one of five listed ingredients. The company does not present it as evidence that the formula will produce outcomes reported in any individual ginseng study.

Branched-Chain Amino Acids Are Primarily Studied in Exercise Settings

The three branched-chain amino acids are leucine, isoleucine and valine. They are essential amino acids, meaning the body must get them from food. Common sources include meat, dairy, eggs and legumes. The 2:1:1 ratio on the MemoHive label means two parts leucine to one part each of isoleucine and valine.

The NIH Office of Dietary Supplements reviews BCAAs mainly in the context of exercise and athletic performance, and reports that evidence of benefit there is limited. Some researchers have explored BCAAs in connection with fatigue during prolonged physical activity. Research on cognitive outcomes in healthy adults remains preliminary.

In MemoHive Premium Formula, the BCAA blend should be understood as part of the product’s nutritional makeup, not as confirmation of any particular outcome.

Ingredient Studies Are Not Finished-Formula Studies

A central point of MemoHive’s announcement is the difference between ingredient research and evidence for a specific product.

Scientific studies usually test a single ingredient at a defined amount under controlled conditions. A commercial supplement may use a different form, concentration or combination. When several studied ingredients are combined in one formula, that alone does not show the combination will produce an additive, equivalent or enhanced result.

MemoHive has not presented a randomized controlled clinical trial of the complete MemoHive Premium Formula. The studies cited in this announcement are background literature on individual ingredients and should not be treated as clinical validation of the product.

“Consumers should be able to tell the difference between an ingredient that has been studied and a specific product that has been clinically evaluated,” Kevin Shaw said. “Those are two different standards of evidence. We think explaining that difference is more useful than attaching citations to a product claim.”

Capsule Format and Serving Information

MemoHive Premium Formula comes as capsules, 60 per bottle. The suggested serving is two capsules once daily, so each bottle is a 30-day supply.

The company does not claim that the capsule format is more effective than tablets, powders or liquid supplements. How well an ingredient is absorbed depends on its chemical form, the formulation, the concentration and the individual. No comparative research on MemoHive has been cited to support conclusions about absorption.

Responsible Use Remains Part of the Product Information

Dietary supplements are not appropriate for everyone. Botanical extracts and amino acids can interact with medications or existing health conditions.

NCCIH advises consumers to tell their healthcare providers about any dietary supplements they use. Panax Ginseng, for example, may interact with certain prescription medications.

Adults who take prescription medication, are pregnant or nursing, have an existing health condition, or are combining several supplements should read the product label and talk with a qualified healthcare professional before use.

MemoHive Premium Formula is a dietary supplement. The company does not position it as a substitute for professional evaluation, prescribed treatment, balanced nutrition, adequate sleep or physical activity.

Regulatory and Research Transparency

The scientific references in this announcement are independent studies of individual ingredients. Citing them does not mean the researchers, academic institutions, NIH, NCCIH, the European Medicines Agency or any other cited organization endorses MemoHive. It also does not mean the complete formula will produce the outcomes described in those studies.

These statements have not been evaluated by the U.S. Food and Drug Administration. MemoHive Premium Formula is not intended to diagnose, treat, cure or prevent any disease.

About MemoHive

MemoHive is a dietary supplement company based in Pinellas Park, Florida. It markets MemoHive Premium Formula, a two-capsule supplement containing Bacopa Monnieri, Rhodiola Rosea, L-Theanine, Panax Ginseng and branched-chain amino acids, with each ingredient listed on the label.

Media & Corporate Communications Contact
Kevin Shaw, Media Relations Manager, MemoHive
1201 N Orange Street, Pinellas Park, FL 33781, USA
Email: contact@getmemohive.com
Telephone: (888) 338-0317

Scientific References

Kongkeaw C., et al., “Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.” Journal of Ethnopharmacology, 2014.

European Medicines Agency, “Community herbal monograph on Rhodiola rosea L., rhizoma et radix.” Describes Rhodiola’s traditional-use status for temporary relief of stress-related symptoms.

National Center for Complementary and Integrative Health, “Rhodiola.” Notes that research on Rhodiola in people is limited.

Nobre A.C., Rao A., Owen G.N., “L-theanine, a natural constituent in tea, and its effect on mental state.” Asia Pacific Journal of Clinical Nutrition, 2008.

Geng J., et al., “Ginseng for cognition.” Cochrane Database of Systematic Reviews, 2010. Concluded that the evidence was not sufficient to support cognitive benefit claims.

National Center for Complementary and Integrative Health, “Asian Ginseng.” Reviews research status and possible medication interactions.

National Institutes of Health Office of Dietary Supplements, “Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals.” Reviews BCAA research in exercise settings.